Status:
COMPLETED
Analgesia for Total Hip Arthroplasty With PENG Block (ATHAPENG)
Lead Sponsor:
Hospices Civils de Lyon
Conditions:
Total Hip Arthroplasty for Osteoarthritis
Eligibility:
All Genders
18+ years
Brief Summary
Analgesia for Total Hip Arthroplasty with PENG block (ATHAPENG)
Detailed Description
Total hip arthroplasty (THA) for osteoarthritis is a commonly performed surgery worldwide. It is associated with significant pain, with median pain scores in the first 24 hours postoperatively exceedi...
Eligibility Criteria
Inclusion
- Adult patients (\> 18 years old)
- Undergoing primary hip arthroplasty for osteoarthritis
- Under general aneasthesia
- With PENG block
Exclusion
- Patient under 18 years old
- Severe cognitive impairment or patient under guardianship
- Pregnancy
- Allergy to local anaesthetics
- Chronic pain with daily opioid consumption
- Non sinusal cardiac rhythm
Key Trial Info
Start Date :
June 25 2024
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 21 2025
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT06954207
Start Date
June 25 2024
End Date
March 21 2025
Last Update
May 1 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Edouard Herriot hospital, hospices civils de Lyon
Lyon, France, 69000